The Diphtheria, Pertussis, and Tetanus (DTP) vaccine market is witnessing steady growth due to increasing global immunization coverage, strong government initiatives, and rising awareness about preventable infectious diseases. DTP vaccines remain a cornerstone of pediatric immunization programs worldwide, protecting infants and children against three life-threatening bacterial infections. As countries strengthen vaccination programs and healthcare access improves, demand for DTP vaccines continues to expand across developed and emerging economies. Read More - https://www.theinsightpartners.com/reports/diphtheria-pertussis-and-tetanus-dtp-vaccine-market